Sign in to view content

Subgroup Analyses From the Phase 3 PULSAR Trial of Aflibercept 8 mg in Patients With Treatment-Naïve Neovascular Age-Related Macular Degeneration

Keyvan Koushan, MD, FRCSC

Video
Published 2023

Related

Episode 9: Rate of Macular Atrophy in HARBOR Study with Dr. SriniVas Sadda
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Episode 146: Journal Club Discussing PIVOT trial, FLUID trial, Timing of Macula-Off RDs
Jayanth Sridhar, MD
Member Podcasts
2018
An Assessment of the Impact of Disease Activity Criteria on Dosing Interval Assignment in Clinical Trial Patients With nAMD
Marco A. Zarbin, MD, PhD
Annual Meeting Talks
2023

Category: AMD-Neovascular

See more